Abstract:OBJECTIVE:To investigate the effects of oxidized-low density lipoprotein (ox-LDL) and urotensin II (U II) on the proliferation of rat aortic smooth muscle cells (VSMCs) and the effect of ox-LDL on the mRNA expression of U II receptor GPR14 in. METHODS:Rat VSMCs were incubated with UII and ox-LDL at different concentrations. The viability of rat VSMCs was detected by MTT assay. Rat VSMCs were incubated with ox-LDL at the concentrations of 0, 0.1, 1, 10, and 50 microg/ml. Twelve hours later competitive RT-PCR was used to detect the effects of concentration of ox-LDP on the mRNA expression of GPR14 in the VSMCs. Another VSMCs were incubated with ox-LDL at the final concentration of 50 microg/ml, and 0, 2, 6, 12, and 24 hours later competitive RT-PCR was used to detect the mRNA expression of GPR14 in the VSMCs. (125)I-labelled U II was added into the culture fluid of VSMCs, and radioligand binding assay was used to calculate the maximum binding (B(max)). RESULTS:UII of the concentration of 50 nmol/L significantly increased the proliferation of VSMCs. When the concentration of ox-LDL was 10 microg/ml the proliferation of VSMCs (P < 0.01) was 0.678 +/- 0.061, increased by 121% compared with the control group (0.325 +/- 0.052, P < 0.01). 0.01 microg/ml of ox-LDL and 10 nmol/L of UII showed a synergistic effect on the proliferation of VSMCs with the MTT value increased to 162% +/- 29% that of the control group (P < 0.01). When the concentration of ox-LDL increase to 0.1 microg/ml the synergistic effect was attenuated with the MTT value of 153% +/- 22% that of the control group (P < 0.05) and when the concentration of ox-LDL increased to 1 microg/ml the synergistic effect diminished, with a MTT value of 123% +/- 13% that of the control group (P > 0.05). When the concentration of ox-LDL was 50 microg/ml the proliferation of VSMCs the MTT value decreased to 59% that of the of control group, however, ox-LDL of the concentration of 50 microg/ml combined with UII of the concentration of 10 nmol/L the MTT value increased to 68% that of the control group, showing that UII of that concentration significantly inhibited the cytotoxic effect of ox-LDL. Incubation of VSMCs with the ox-LDL at the concentration of 0.1 microg/ml the GPR14 mRNA expression of the VSMCs was 125.1% that of the control group (P < 0.01) as assessed by competitive RT-PCR, however, when the concentration of ox-LDL increased over 1 microg/ml the GPR14 mRNA expression does-dependently decreased as much as 72.6% that of the control group (all P < 0.01), with the maximal effect when the concentration of ox-LDL reached 50 microg/ml. ox-LDL at the concentration of 50 microg/ml time-dependently down-regulated the GPR14 mRNA expression with the maximal effect 12 hours after addition of ox-LDL and this effect was sustained for up to 24 hours. After incubation for 12 hours the binding of (125)I-UII to VSMCs was 117.5% that of the control group (P < 0.01) with the ox-LDL at the concentration of 0.1 microg/ml, and was 68.8% that of the control group (P < 0.01) with the ox-LDL at the concentration of 50 microg/ml. CONCLUSION:ox-LDL and with U-II. GPR14 at certain concentrations show synergetic effects on the proliferation of VSMCs. The GPR14 mRNA expression in VSMCs can be upregulated by low concentration of ox-LDL, while downregulated by high concentration of ox-LDL.

[Impact of Human Urotensin II on the Pulmonary Arterial Smooth Muscle Cells Cycle in Normoxic/hypoxic Rats].

Effects of Hypoxia on Levels of Nitric Oxide, Endothelin- 1 and Inducible Nitric Oxide Synthase Mrna Expression in Cultured Human Umbilical Vein Endothelial Cells

Proliferation and Anti-Apoptotic Effects of Human Urotensin II on Human Endothelial Cells

Overexpression of ACE2 Prevents Hypoxia-Induced Pulmonary Hypertension in Rats by Inhibiting Proliferation and Immigration of PASMCs.

Effect of Chronic Hypoxia on Contents of Urotensin II and Its Functional Receptors in Rat Myocardium

[Impact of High Pulmonary Blood Flow on Pulmonary Vascular Structure and Human Urotensin II in Intrapulmonary Arteries of Rats].

The Signal Transduction Pathway in the Proliferation of Airway Smooth Muscle Cells Induced by Urotensin II.

Urotensin II Accelerates Cardiac Fibrosis and Hypertrophy of Rats Induced by Isoproterenol.

Abstract P148: Urotensin II Impairs Cardiac Functions and Proliferation of Cardiac Side Population Cells in Mice During Chronic Pressure Overload.

Effects of Human Urotension Ⅱ on in Vivo Mesenteric Microcirculation in Rats

[Effect of Urotensin II on Secretion of Adrenomedullin from Human Vascular Endothelial Cells].

Urotensin II Receptor in the Rat Airway Smooth Muscle and Its Effect on the Rat Airway Smooth Muscle Cells Proliferation.

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits

Abstract 265: Uroetensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress Through Cystathionine-γ-Lyase (cse)/hydrogen Sulfide Pathway

Urotensin II Inhibits the Proliferation but Not the Differentiation of Cardiac Side Population Cells

[Change and Clinical Implication of Urotensin II in Plasma and Induced Sputum of Chronic Obstructive Pulmonary Disease].

Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress Through the CSE/H2S Pathway

The Role of Hydrogen Sulfide System on Pulmonary Artery Smooth Muscle Cells Cultured of Rats in Hypoxia Condition

The in vivo effects of human urotensin II in the rabbit and rat pulmonary circulation: effects of experimental pulmonary hypertension

[Effects of Oxidized-Low Density Lipoprotein on Expression of Urotensin II Receptor GPR14 in Rat Aortic Smooth Muscle Cells].

Mitogenic Effect of Urotensin Ⅱ on Cells